Julia Meißner

5.4k total citations · 1 hit paper
72 papers, 2.5k citations indexed

About

Julia Meißner is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Julia Meißner has authored 72 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pathology and Forensic Medicine, 28 papers in Oncology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Julia Meißner's work include Lymphoma Diagnosis and Treatment (46 papers), Lung Cancer Treatments and Mutations (23 papers) and CAR-T cell therapy research (13 papers). Julia Meißner is often cited by papers focused on Lymphoma Diagnosis and Treatment (46 papers), Lung Cancer Treatments and Mutations (23 papers) and CAR-T cell therapy research (13 papers). Julia Meißner collaborates with scholars based in Germany, Switzerland and Spain. Julia Meißner's co-authors include Raphael Twerenbold, Tobias Reichlin, Christian Mueller, Miriam Reiter, Katrin Winkler, Philip Haaf, Willibald Hochholzer, Peter Borchmann, Claudia Stelzig and Michael Fuchs and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Julia Meißner

65 papers receiving 2.4k citations

Hit Papers

Fertility preservation and post-treatment pregnancies in ... 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†
    2020 281 citations Julia Meißner et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Meißner Germany 26 1.0k 703 676 572 344 72 2.5k
Alexandra W. van den Belt‐Dusebout Netherlands 17 603 0.6× 947 1.3× 729 1.1× 414 0.7× 710 2.1× 27 3.2k
Margreet H.A. Baaijens Netherlands 17 892 0.9× 605 0.9× 749 1.1× 666 1.2× 378 1.1× 22 2.5k
Wouter E.M. Kok Netherlands 26 1.8k 1.8× 170 0.2× 312 0.5× 443 0.8× 421 1.2× 69 2.9k
Cezar Iliescu United States 27 2.3k 2.3× 151 0.2× 1.1k 1.7× 840 1.5× 581 1.7× 175 3.8k
Michael G. Fradley United States 28 2.0k 2.0× 116 0.2× 1.4k 2.0× 501 0.9× 313 0.9× 139 3.5k
Dario Casara Italy 33 629 0.6× 212 0.3× 457 0.7× 385 0.7× 1.8k 5.3× 130 4.0k
H. Anderson Sweden 28 244 0.2× 579 0.8× 1.4k 2.1× 106 0.2× 333 1.0× 51 2.8k
Cécile P.M. Janus Netherlands 13 679 0.7× 357 0.5× 266 0.4× 499 0.9× 100 0.3× 33 1.3k
Janine Nuver Netherlands 21 523 0.5× 188 0.3× 452 0.7× 115 0.2× 796 2.3× 70 1.8k
P. J. S. M. Kerstens Netherlands 30 146 0.1× 582 0.8× 201 0.3× 300 0.5× 131 0.4× 68 3.9k

Countries citing papers authored by Julia Meißner

Since Specialization
Citations

This map shows the geographic impact of Julia Meißner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Meißner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Meißner more than expected).

Fields of papers citing papers by Julia Meißner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Meißner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Meißner. The network helps show where Julia Meißner may publish in the future.

Co-authorship network of co-authors of Julia Meißner

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Meißner. A scholar is included among the top collaborators of Julia Meißner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Meißner. Julia Meißner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Bröckelmann, Paul J., Peter Herhaus, Julia Meißner, et al.. (2023). Fertility and Gonadal Function after First-Line Treatment with Nivolumab-AVD in Hodgkin Lymphoma Patients: An Analysis from the Phase II GHSG Nivahl Trial. Blood. 142(Supplement 1). 4456–4456.
4.
Meißner, Julia, et al.. (2023). Combination of Secondary Plant Metabolites and Micronutrients Improves Mitochondrial Function in a Cell Model of Early Alzheimer’s Disease. International Journal of Molecular Sciences. 24(12). 10029–10029. 1 indexed citations
5.
6.
Meißner, Julia, et al.. (2020). A Severe Case of Anaplastic Large Cell Lymphoma in a Previously Healthy Woman: Diagnostic and Therapeutic Challenges. SHILAP Revista de lepidopterología. 121(4). 262–266.
7.
Dietrich, Sascha, Thuong Hien Tran, Thomas Luft, et al.. (2020). The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysis. Bone Marrow Transplantation. 56(1). 30–37. 6 indexed citations
8.
Fosså, Alexander, Helen Goergen, Peter Kamper, et al.. (2018). B-CAP (brentuximab vedotin, cyclophosphamide, doxorubicin and predniso(lo)Ne) in Older Patients with Advanced-Stage Hodgkin Lymphoma: Results of a Phase II Intergroup Trial By the German Hodgkin Study Group (GHSG) and the Nordic Lymphoma Group (NLG). Kölner Universitäts PublikationsServer (Universität zu Köln).
9.
Meißner, Julia, Hervé Finel, Sascha Dietrich, et al.. (2016). Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience. Bone Marrow Transplantation. 52(4). 650–652. 23 indexed citations
10.
Meißner, Julia, Diana Tichy, Verena Katzke, et al.. (2015). Long-term ovarian function in women treated with CHOP or CHOP plus etoposide for aggressive lymphoma. Annals of Oncology. 26(8). 1771–1776. 20 indexed citations
11.
Spoerl, Silvia, Susanne Schnittger, Julia Meißner, et al.. (2013). Imatinib failure and response to dasatinib in a patient with chronic myeloid leukemia in blast crisis and a novel, nine-nucleotide BCR-ABL insertion mutation. Blood Cancer Journal. 3(3). e104–e104. 4 indexed citations
12.
Haaf, Philip, Beatrice Drexler, Tobias Reichlin, et al.. (2012). High-Sensitivity Cardiac Troponin in the Distinction of Acute Myocardial Infarction From Acute Cardiac Noncoronary Artery Disease. Circulation. 126(1). 31–40. 101 indexed citations
13.
Meune, Christophe, Raphael Twerenbold, Beatrice Drexler, et al.. (2012). Midregional Pro–A-Type Natriuretic Peptide for Diagnosis and Prognosis in Patients With Suspected Acute Myocardial Infarction. The American Journal of Cardiology. 109(8). 1117–1123. 12 indexed citations
14.
Meißner, Julia, Holger Nef, Mária Kovács, et al.. (2011). Endogenous stress response in Tako-Tsubo cardiomyopathy and acute myocardial infarction. European Journal of Clinical Investigation. 41(9). 964–970. 16 indexed citations
15.
Haaf, Philip, Cathrin Balmelli, Tobias Reichlin, et al.. (2011). N-terminal Pro B-type Natriuretic Peptide in the Early Evaluation of Suspected Acute Myocardial Infarction. The American Journal of Medicine. 124(8). 731–739. 25 indexed citations
16.
Irfan, Affan, Philip Haaf, Julia Meißner, et al.. (2011). Systolic blood pressure at Emergency Department presentation and 1-year mortality in acute chest pain patients. European Journal of Internal Medicine. 22(5). 495–500. 2 indexed citations
17.
Noveanu, Markus, Tobias Breidthardt, Mihael Potocki, et al.. (2011). Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure. Critical Care. 15(1). R1–R1. 76 indexed citations
18.
Socrates, Thenral, Christopher R. deFilippi, Tobias Reichlin, et al.. (2010). Interleukin family member ST2 and mortality in acute dyspnoea. Journal of Internal Medicine. 268(5). 493–500. 36 indexed citations
19.
20.
Kasper, Bernd, Julia Meißner, Frauke Bellos, et al.. (2004). Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?. Supportive Care in Cancer. 12(3). 205–207. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandra W. van den Belt‐Dusebout Breakdown of academic impact, for papers by Margreet H.A. Baaijens Breakdown of academic impact, for papers by Wouter E.M. Kok Breakdown of academic impact, for papers by Cezar Iliescu Breakdown of academic impact, for papers by Michael G. Fradley Breakdown of academic impact, for papers by Dario Casara Breakdown of academic impact, for papers by H. Anderson Breakdown of academic impact, for papers by Cécile P.M. Janus Breakdown of academic impact, for papers by Janine Nuver Breakdown of academic impact, for papers by P. J. S. M. Kerstens
Rankless by CCL
2026